Jeffrey’s Legacy Becomes Larger Than LeukemiaThe Jeffrey Pride Foundation will soon mark 25 years of giving to pediatric cancer research. As they fundraise, they honor the life of their namesake with steadfast hope for more effective treatments. This year, one of several research projects they support is going global and aims to improve outcomes for children with the same rare type of leukemia their friend Jeffrey had.
|
A Young Football Player’s Legacy Helps Science Tackle OsteosarcomaSmart and athletic. Kind and creative. Mason Allen was a kid everyone adored. Five years after his passing, Mason’s legacy was a catalyst for Dr. John Doski’s research into game-changing knowledge in diagnosing, treating and operating on pediatric osteosarcoma patients – the same cancer Mason had.
|